Astellas Pharma Inc
Astellas Pharma's Climate Target Data Preview
As of 2024, Astellas Pharma has disclosed 4 climate targets aimed at reducing its greenhouse gas (GHG) emissions. These include 4 absolute reduction targets, signaling the company’s commitment to managing and lowering its carbon footprint over time. The targets span various emissions scopes and time horizons, offering insight into Astellas Pharma ’s climate strategy, ambition level, and alignment with global decarbonization goals.
| Target Type | Scope of Target | Unit | Target | Target Year |
|---|---|---|---|---|
Absolute-based Target | Scope 1 - Total, Scope 2 - Total | Metric Tonnes of CO2 equivalent (mtCO2e) | Copy restricted. Please purchase to unlock this data.  | 2030 |
Absolute-based Target | Scope 3 - Total | Metric Tonnes of CO2 equivalent (mtCO2e) | Copy restricted. Please purchase to unlock this data.  | 2030 |
Absolute-based Target | Scope 1 - Total, Scope 2 - Total | Metric Tonnes of CO2 equivalent (mtCO2e) | Copy restricted. Please purchase to unlock this data.  | 2050 |
Absolute-based Target | Scope 3 - Total | Metric Tonnes of CO2 equivalent (mtCO2e) | Copy restricted. Please purchase to unlock this data. | 2050 |
This table provides a simplified preview of selected climate targets data points. To access the complete dataset with full disclosures, detailed breakdowns, and source traceability, create a free account to view purchase options.
Insights into Astellas Pharma's Greenhouse Gas Emissions Pathways
As of 2024, Astellas Pharma has set greenhouse gas (GHG) emissions reduction targets that cover both its operational emissions (Scope 1 and 2) and value chain emissions (Scope 3), offering a comprehensive view of its total carbon footprint.
Does Astellas Pharma have a target to reduce the emissions from its operations?
As of 2024, Astellas Pharma has set a target to reduce its operational greenhouse gas (GHG) emissions, specifically those from Scope 1 and Scope 2 sources.
Astellas Pharma's most ambitious operational target is to reduce these emissions by 90% by 2050, compared to a baseline of 203,000 Metric Tonnes of CO2 equivalent (mtCO2e) in 2015.
As of 2023, Astellas Pharma is ahead of schedule on its operational emissions reduction target, having achieved 44.22% of the planned reduction.
Astellas Pharma's Operational (Scope 1+2) Emissions Pathway
Does Astellas Pharma have a target to reduce the emissions from its value chain?
As of 2024, Astellas Pharma has set a target to reduce its value chain greenhouse gas (GHG) emissions, covering 1 out of the 15 Scope 3 categories defined by the GHG Protocol.
Astellas Pharma's most ambitious value chain target is to reduce these emissions by 90% by 2050, compared to a baseline of 1,378,972 Metric Tonnes of CO2 equivalent (mtCO2e) in 2015.
As of 2023, Astellas Pharma is lagging behind on its value chain emissions reduction target, having achieved 20.76% of the planned reduction.